You are here: Industry Insights > Pfizer

News List

FDA limits Xeljanz in colitis, slaps black box on label biospectrumasia
July 30, 2019
For Pfizer’s blockbuster immunology drug Xeljanz, an FDA safety communication has now turned into a boxed warning. And forget the drug's approval as a first-line ulcerative colitis treatment, at least for now.
FDA adds boxed warning to Pfizer’s Xeljanz drug in ulcerative colitis pharmaceutical-technology
July 30, 2019
The US Food and Drug Administration (FDA) has approved boxed warning of higher blood clots and death risk with 10mg twice-daily dose of Pfizer’s Xeljanz (tofacitinib) drug in ulcerative colitis patients.
Syapse, Pfizer in Oncology Precision Medicine Pact contractpharma
July 25, 2019
o focus on outcomes research using Real-World Evidence.
FDA approves nine generics of Pfizer’s Lyrica drug pharmaceutical-technology
July 24, 2019
The US Food and Drug Administration (FDA) has approved nine generic versions of Pfizer’s nerve pain drug Lyrica (pregabalin), which are the first generics approved for the medication.
EC approves GSK-Pfizer consumer health JV with conditions pharmaceutical-technology
July 12, 2019
The European Commission (GSK) has cleared GlaxoSmithKline (GSK) and Pfizer’s proposed merger of respective consumer health businesses to create a joint venture (JV).
NICE recommends Pfizer’s dacomitinib for NSCLC patients pharmaceutical-technology
July 09, 2019
The UK’s National Institute for Health and Care Excellence (NICE) has recommended the use of Pfizer’s dacomitinib (Vizimpro) as a first-line treatment for non-small-cell lung cancer (NSCLC) patients on the National Health Service (NHS).
Sangamo, Pfizer announce updated Phase 1/2 results for SB-525 investigational Hemophilia A gene therapy biospectrumasia
July 08, 2019
In addition to the collaboration for the development and commercialization of gene therapies for hemophilia A, Sangamo and Pfizer are also working together on the development of gene therapies for amyotrophic lateral sclerosis (ALS) and frontotemporal lob
Former FDA Commissioner joins Pfizer’s board of directors europeanpharmaceuticalreview
July 05, 2019
Former FDA Commissioner, Scott Gottlieb, who stepped down from the administration in April, has joined Pfizer’s board of directors.
Pfizer successfully completes the acquisition of Therachon europeanpharmaceuticalreview
July 05, 2019
Pharmaceutical company, Pfizer, has announced it has completed the acquisition of Therachon for $340 million.
TILT Biotherapeutics to Collaborate with Merck KGaA and Pfizer contractpharma
July 04, 2019
To investigate the combination of oncolytic virus, TILT-123, and anti-PDL1 antibody, avelumab.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page